INS and hepatocellular carcinoma: Furthermore, anti-diabetic agents such as sulfonylureas and insulin [7,8] are associated with an increased risk of HCC in contrast to metformin [7,9,10,11,12] and thiazolidinediones [7,13], which are associated with a reduced risk of HCC development.